TET repression and increased DNMT activity synergistically induce aberrant DNA methylation

Area of Science:

• Epigenetics
• Molecular Biology
• Inflammation Research

Background:

• Chronic inflammation is linked to various diseases, including cancer and neurodegenerative disorders.
• Aberrant DNA methylation is a key epigenetic mechanism in these disorders, but its induction pathways remain unclear.

Purpose of the Study:

• To elucidate the mechanisms driving aberrant DNA methylation during chronic inflammation.
• To investigate the roles of TET enzymes, microRNAs, NF-κB signaling, nitric oxide (NO), and DNA methyltransferases (DNMTs) in this process.

Main Methods:

• Analysis of TET gene expression in inflamed mouse and human tissues.
• Investigation of TET-targeting microRNAs (MIR20A, MIR26B, MIR29C) and their link to NF-κB signaling.
• Assessment of TET knockdown effects on DNA methylation.
• Evaluation of nitric oxide (NO) production by NOS2 and its impact on DNMT activity.
• Examination of the combined effects of TET knockdown and NO exposure on DNA methylation patterns.

Main Results:

• TET gene expression was downregulated in inflamed tissues due to increased TET-targeting microRNAs, driven by NF-κB activation.
• TET knockdown alone induced only mild aberrant methylation.
• Nitric oxide (NO) enhanced DNMT activity, causing minimal aberrant methylation.
• Combined TET knockdown and NO exposure synergistically induced aberrant DNA methylation in previously unmethylated genomic regions.

Conclusions:

• Aberrant DNA methylation in chronic inflammation results from a synergistic interaction between TET repression (via NF-κB) and DNMT activation (via NO).
• This dual mechanism contributes significantly to the epigenetic alterations observed in human inflammatory diseases.